athenahealth, Inc. (ATHN) Stake Decreased by Bank of New York Mellon Corp

Bank of New York Mellon Corp lowered its stake in shares of athenahealth, Inc. (NASDAQ:ATHN) by 5.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 329,174 shares of the health services provider’s stock after selling 18,231 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.82% of athenahealth worth $40,936,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in ATHN. Dimensional Fund Advisors LP grew its position in shares of athenahealth by 37.3% during the first quarter. Dimensional Fund Advisors LP now owns 121,650 shares of the health services provider’s stock worth $13,708,000 after buying an additional 33,061 shares in the last quarter. Aperio Group LLC lifted its stake in athenahealth by 10.6% in the second quarter. Aperio Group LLC now owns 6,709 shares of the health services provider’s stock valued at $943,000 after buying an additional 641 shares during the last quarter. Bessemer Group Inc. lifted its stake in athenahealth by 13.7% in the second quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock valued at $132,000 after buying an additional 113 shares during the last quarter. World Asset Management Inc bought a new stake in athenahealth in the second quarter valued at $253,000. Finally, Seven Bridges Advisors LLC raised its stake in shares of athenahealth by 5.4% during the second quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock valued at $183,000 after purchasing an additional 67 shares in the last quarter.

athenahealth, Inc. (NASDAQ ATHN) opened at $133.78 on Thursday. The firm has a market capitalization of $5,356.37, a PE ratio of 113.43, a P/E/G ratio of 5.02 and a beta of 1.57. athenahealth, Inc. has a 12 month low of $90.11 and a 12 month high of $158.66. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.67 and a quick ratio of 1.67.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.06. The firm had revenue of $304.60 million for the quarter, compared to analysts’ expectations of $310.52 million. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. athenahealth’s revenue was up 10.1% on a year-over-year basis. During the same quarter last year, the business posted $0.60 EPS. analysts expect that athenahealth, Inc. will post 1.2 earnings per share for the current fiscal year.

In related news, SVP Bradford Kyle Armbrester sold 1,000 shares of athenahealth stock in a transaction dated Friday, October 27th. The stock was sold at an average price of $128.56, for a total value of $128,560.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Jonathan D. Porter sold 300 shares of athenahealth stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $130.38, for a total value of $39,114.00. The disclosure for this sale can be found here. Insiders sold a total of 9,283 shares of company stock worth $1,175,908 in the last three months. 3.20% of the stock is currently owned by company insiders.

ATHN has been the topic of a number of recent analyst reports. Wells Fargo & Company cut their price objective on shares of athenahealth from $190.00 to $155.00 and set an “outperform” rating on the stock in a research note on Monday, October 23rd. Oppenheimer restated a “buy” rating and set a $184.00 price objective on shares of athenahealth in a research note on Friday, October 20th. KeyCorp restated a “buy” rating and set a $170.00 price objective on shares of athenahealth in a research note on Sunday, September 17th. TheStreet cut shares of athenahealth from a “b-” rating to a “c+” rating in a research note on Wednesday, October 11th. Finally, First Analysis upgraded shares of athenahealth from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $125.00 to $127.00 in a research note on Monday, October 23rd. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and eleven have given a buy rating to the stock. athenahealth presently has an average rating of “Hold” and an average target price of $143.22.

ILLEGAL ACTIVITY WARNING: This report was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.chaffeybreeze.com/2017/12/07/athenahealth-inc-athn-stake-decreased-by-bank-of-new-york-mellon-corp.html.

athenahealth Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply